Urszula R.
- Country
- Poland
- Department
- ClinHouse Centrum Medyczne
Research Overview
- Phase 2a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of VENT-03 in Adults with Active Cutaneous Lupus Erythematosus
- A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults with Systemic Sclerosis
Data & Insights
Has run more than one trial at 1 of 39 partner sites.
Specializations
Schizophrenia and cognitive impairment
Clinical research activity includes therapeutic development for schizophrenia, with attention to negative symptoms, cognitive impairment, and persistent illness that does not respond adequately to standard antipsychotic treatment.
- Negative symptoms of schizophrenia
- Treatment-resistant schizophrenia
- Cognitive impairment associated with schizophrenia
Interest also extends to longer-term treatment safety in people living with chronic psychotic disorders.
Alzheimer’s disease and dementia-related agitation
Research involvement covers Alzheimer’s disease and behavioral symptoms linked to dementia, especially agitation in patients with Alzheimer-type dementia and related cognitive decline.
- Agitation in Alzheimer’s disease dementia
- Cognitive symptoms in mild to moderate Alzheimer’s disease
- Behavioral disturbance in dementia
The therapeutic focus includes symptom control in neurodegenerative disease and support for cognitive function.
Neuroimmunology and neuromuscular disease
Clinical activity includes immune-mediated disorders affecting the nervous system, with involvement in multiple sclerosis and generalized myasthenia gravis, reflecting interest in disease-modifying and symptom-directed therapies.
- Relapsing-remitting multiple sclerosis
- Generalized myasthenia gravis
- Long-term treatment safety in chronic neuroimmune disease
This area also includes evaluation of therapies intended to maintain disease control in neurologic autoimmunity.
Respiratory, metabolic, and addiction medicine
Research interests also span common internal medicine and behavioral health domains, including chronic obstructive pulmonary disease, type 2 diabetes, and alcohol addiction.
- Chronic obstructive pulmonary disease
- Type 2 diabetes
- Alcohol dependence
These studies reflect engagement with therapies aimed at reducing exacerbations, improving glycaemic control, and supporting reduction in alcohol consumption.
Autoimmune and inflammatory disorders
Clinical work further includes cutaneous lupus erythematosus and systemic sclerosis, indicating involvement in inflammatory connective tissue diseases with skin and systemic manifestations.
- Cutaneous lupus erythematosus
- Systemic sclerosis
- Skin and fibrotic disease activity
These areas align with therapeutic interest in disease activity reduction and management of chronic autoimmune burden.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.